Financial News · Live Terminal

Page 337 of 340

Burke & Herbert Financial, Linkbancorp Get Regulatory Approvals for Pending Merger

Burke & Herbert Financial Services (BHRB) and Linkbancorp (LNKB) said Monday that they have received all the regulatory approvals needed to complete their merger.The merger is set to close May 1.

$BHRB$LNKB

Wire71d ago

Mizuho Adjusts Price Target on Marsh & McLennan to $193 From $199, Maintains Neutral Rating

Marsh & McLennan (MRSH) has an average rating of hold and mean price target of $203.95, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $170.06, Change: $+1.91, Percent Change: +1.14%

$MRSH

Wire71d ago

Market Chatter: Goldman Sachs Launches Three-Part Investment-Grade Bond Offering

Goldman Sachs (GS) is launching a new three-tranche offering in the US investment-grade debt market, with bond maturities spanning four to eight years, Bloomberg said Monday, citing a person with direct knowledge of the matter.Initial price talks on the longest maturity is a spread of 1.25 percentage points over US Treasuries, the person said, according to the report.Goldman Sachs did not immediately respond to' request for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $872.43, Change: $-35.37, Percent Change: -3.90%

$GS

Wire71d ago

T. Rowe Price Reports Lower Assets Under Management in March

T. Rowe Price Group (TROW) said Monday that it had assets under management of $1.71 trillion at the end of March, down from $1.803 trillion at the end of February.The company said net outflows for March were $3.2 billion.Price: $91.63, Change: $+0.14, Percent Change: +0.15%

$TROW

Wire71d ago

Rumble Launches Tender Offer for Northern Data Shares

Rumble (RUM) said Monday it launched its exchange offer for all outstanding Northern Data shares as part of its planned business combination with the Germany-based AI and high-performance computing infrastructure provider.Under the offer, shareholders will receive 2.0281 newly issued shares of Rumble Class A common stock for each Northern Data share. The tender offer period ends at 12:01 am ET on May 9, according to a statement.Rumble said it has secured commitments from shareholders holding approximately 72% of Northern Data's outstanding shares. The company added that the tender offer has no minimum acceptance threshold.Northern Data shares are expected to be delisted from the open market promptly following the close of the tender offer, the statement said.Price: $4.95, Change: $-0.04, Percent Change: -0.90%

$RUM

Wire71d ago

Mizuho Adjusts Price Target on Everest Group to $365 From $360, Maintains Neutral Rating

Everest Group (EG) has an average rating of hold and mean price target of $361.19, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $328.73, Change: $-1.14, Percent Change: -0.35%

$EG

Wire71d ago

BMO Capital Adjusts Price Target on Avery Dennison to $222 From $224, Maintains Outperform Rating

Avery Dennison (AVY) has an average rating of overweight and mean price target of $209.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $169.03, Change: $-2.13, Percent Change: -1.25%

$AVY

Wire71d ago

BMO Capital Adjusts Price Target on Public Service Enterprise Group to $91 From $90, Maintains Market Perform Rating

Public Service Enterprise Group Inc (PEG) has an average rating of overweight and mean price target of $91.47, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $82.39, Change: $-0.74, Percent Change: -0.89%

$PEG

Wire71d ago

Mizuho Adjusts Price Target on Boston Scientific to $90 From $115, Maintains Outperform Rating

Boston Scientific (BSX) has an average rating of buy and mean price target of $98.71, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $62.46, Change: $+0.67, Percent Change: +1.08%

$BSX

Wire71d ago

Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating

ResMed (RMD) has an average rating of overweight and mean price target of $305.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $228.56, Change: $-0.31, Percent Change: -0.14%

$RMD

Wire71d ago

BMO Capital Adjusts Price Target on Qnity Electronics to $146 From $142, Maintains Outperform Rating

Qnity Electronics, Inc. (Q) has an average rating of buy and mean price target of $140.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $133.94, Change: $+3.29, Percent Change: +2.52%

Wire71d ago

Mizuho Adjusts Price Target on Intuitive Surgical to $525 From $575, Maintains Neutral Rating

Intuitive Surgical (ISRG) has an average rating of overweight and mean price target of $602.18, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $453.27, Change: $+2.65, Percent Change: +0.59%

$ISRG

Wire71d ago

BMO Capital Adjusts Price Target on CMS Energy to $86 From $80, Maintains Outperform Rating

CMS Energy (CMS) has an average rating of overweight and mean price target of $81.58, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $78.60, Change: $-0.78, Percent Change: -0.98%

$CMS

Wire71d ago

BMO Capital Adjusts Price Target on Dow to $42 From $35, Maintains Market Perform Rating

Dow (DOW) has an average rating of overweight and mean price target of $39.35, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.02, Change: $+1.01, Percent Change: +2.59%

$DOW

Wire71d ago

Mizuho Adjusts Price Target on Edwards Lifesciences to $95 From $100, Maintains Outperform Rating

Edwards Lifesciences (EW) has an average rating of overweight and mean price target of $97.27, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $77.90, Change: $+0.03, Percent Change: +0.04%

$EW

Wire71d ago

BMO Capital Adjusts Price Target on ServiceNow to $120 From $170, Maintains Outperform Rating

ServiceNow (NOW) has an average rating of buy and mean price target of $179.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $87.53, Change: $+4.53, Percent Change: +5.46%

$NOW

Wire71d ago

Vir Biotechnology Doses First Expansion Cohort Patient in Phase 1 Metastatic Prostate Cancer Trial

Vir Biotechnology (VIR) said Monday it has dosed the first patient in one of three expansion cohorts in a phase 1 trial assessing safety, pharmacokinetics and efficacy of VIR-5500 in metastatic prostate cancer.The company said the monotherapy expansion cohort in late-line metastatic castration-resistant prostate cancer is the first to begin enrollment.Vir said it expects to dose the first patients in the dose-expansion cohorts to evaluate VIR-5500 combined with an androgen receptor pathway inhibitor in early-line metastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer, in the coming months.The company said it expects to launch pivotal phase 3 trials in 2027.Shares of Vir Biotechnology were down 1% in Monday trading.Price: $9.40, Change: $-0.10, Percent Change: -1.05%

$VIR

Wire71d ago

Chemed Signs $450 Million Amended, Restated Credit Agreement

Chemed (CHE) said Monday it has signed an amended and restated agreement for its credit facility.The terms of the agreement comprise a $450 million five-year revolving credit facility including $100 million for letters of credit, the company said.The interest rate of the credit agreement has a floating rate that is generally the secured overnight financing rate, or SOFR, plus an additional tiered rate linked to the company's current leverage ratio, Chemed said.The credit agreement also has an expansion feature allowing the company to increase the revolving facility by an extra $250 million, it said.Price: $386.01, Change: $+0.17, Percent Change: +0.04%

$CHE

Wire71d ago

Labcorp Partners With Children's Hospital of Philadelphia on Pediatric Diagnostics

Labcorp (LH) said Monday it is collaborating with the Children's Hospital of Philadelphia to develop and expand access to pediatric diagnostic tests across the US.Financial terms were not provided.The company said the agreement will combine its laboratory network with the hospital's research and clinical capabilities to support development and broader availability of new tests in areas including oncology, metabolic conditions and autoimmune disorders.Labcorp also said the collaboration is expected to establish a joint pipeline to identify and advance pediatric diagnostics and make them available nationally through its testing infrastructure.Price: $261.71, Change: $+0.76, Percent Change: +0.29%

$LH

Wire71d ago

Supermicro Introduces Three New Edge AI Systems Powered by AMD Processors

Supermicro (SMCI) said Monday that it is introducing three new edge artificial intelligence systems that are powered by Advanced Micro Devices' (AMD) EPYC 4005 series processors.The new AI systems include a compact mini-1U box system, a short-depth 1U rackmount system, and a slim tower system aiming to accelerate AI inferencing and general-purpose workloads in space and power-constrained environments, Supermicro said.Shares of the company were down 3% in recent Monday trading.Price: $24.79, Change: $-0.48, Percent Change: -1.88%

$AMD$SMCI

Showing 6721-6740 of 6795